forest walks and trains others to become forest therapy guides themselves. Learn from Clotilde’s expertise and take the next step in understanding nature’s therapeutic benefits by enrolling in our course. 🌲
Published on May 25, 2026
Anyone working with mushroom preparations runs into the same frustration: a jar promises “high polysaccharides,” clients expect steady outcomes, and then results vary from batch to batch. When suppliers lean on glossy labels instead of batch data, you’re left explaining why one lion’s mane feels different from the next—without ever seeing how the extract was produced. At that point, quality stops being about brand reputation and starts being about what the lab report says for the exact lot you’re holding.
The most reliable starting point is simple: beta‑glucans on the certificate of analysis (COA) are the non‑negotiable anchor for evaluating mushroom products. Read at the batch level—and alongside alpha‑glucans, test methods, and contaminant panels—beta‑glucans help separate genuine fungal material from starch‑heavy fillers and marketing noise. From there, you can turn percentages into comparable daily intake, spot common testing “games,” and still keep mushrooms in their full traditional context rather than reducing them to a single number.
Key Takeaway: Treat beta‑glucans on a batch-matched COA as the baseline authenticity check, then interpret them alongside alpha‑glucans, methods, and contaminant panels. This combination helps you spot starch-inflated “polysaccharide” claims, compare products by real daily intake, and source mushroom preparations with defensible consistency.
A mushroom COA is a one‑page story about a single batch. It tells you what it is, what key compounds show up in testing, and whether basic purity checks were performed.
At its core, a COA is an independent laboratory document confirming what is (and isn’t) in the material being sold. For mushrooms, that usually means identity, carbohydrate markers such as beta‑glucans, and a contaminant panel.
The good news is that most useful COAs repeat the same sections. After you’ve read a handful, your eye learns exactly where to go first.
Identity deserves special respect. Traditional lineages have always treated species as specific—never interchangeable—and modern testing should reflect that same care. While scientific identification often uses ITS sequencing, there’s more evidence for ITS as an identification tool than for its routine inclusion on everyday commercial COAs, so any brand claiming DNA verification should be able to document it clearly.
Seen this way, the COA doesn’t replace traditional knowing—it strengthens it. It’s another set of eyes on identity, composition, and cleanliness.
Beta‑glucans became the main potency marker because they create a measurable bridge between tradition and lab testing. They aren’t the whole mushroom, but they’re one of the clearest checks that you’re actually working with meaningful fungal material.
Practitioners have long valued mushrooms through preparation methods, lineage, and lived results. Modern analysis didn’t invent that wisdom; it simply gave one part of the picture a reliable measurement. Fungal beta‑glucans are major cell‑wall polysaccharides, which makes them a practical proxy for real mushroom content.
Here’s why that matters: fungal cell walls aren’t incidental. They’re central to the mushroom’s structure and closely linked to the broad functional patterns practitioners have observed over generations. Current research notes beta‑glucans can modulate gut microbiota and immune responses, which aligns with why mushrooms often feel “system-wide” in their influence.
Beta‑glucans also rose to the top because the testing is comparatively solid. They can be measured using a validated enzymatic method that distinguishes beta‑glucans from other glucans, so you’re less likely to get inflated numbers from vague carbohydrate testing.
And still: mushrooms are wonderfully complex. They contain many other meaningful constituents, and there are few consensus standards for verifying them across the market. That’s why beta‑glucans became the anchor—not because they explain everything, but because they’re one dependable place to start.
The carbohydrate panel only becomes useful when you read the numbers together. Beta‑glucans reflect fungal cell-wall material, alpha‑glucans often point to starch, and “total polysaccharides” alone is too broad to guide sourcing.
A high polysaccharide number can sound impressive until you ask: “Which polysaccharides?” Without separating beta‑ and alpha‑glucans, a report leaves too much room for interpretation.
Put simply: avoid rigid cut-offs, and look for coherence. Consumer guidance does agree that a concentrated extract marketed as “high potency” should show high beta‑glucans if it truly concentrates fungal constituents.
The contrast is easiest to understand when you look at grain-heavy products. In the Nammex retail survey, many mycelium‑on‑grain supplements showed 66–73% alpha‑glucan and only 1–3% beta‑glucan, which the authors interpreted as largely grain-derived. That doesn’t automatically make them “bad,” but it does mean they’re not compositionally similar to traditional fruiting-body preparations.
If you want a quick rule of thumb, this is the one: high beta‑glucans plus low alpha‑glucans usually signals a cleaner, more mushroom-dense extract. And if all you’re given is a single polysaccharide number, you still don’t have enough to judge quality responsibly.
The biggest red flags are vagueness, missing context, and numbers without a clear test method. A glossy COA that skips the basics is a reason to pause, not proceed.
One common tactic is to present “polysaccharides” as if that automatically means beta‑glucans. It doesn’t. Testing commentary notes starch-rich alpha‑glucans can heavily influence total polysaccharide values, so the headline number can look impressive while actual beta‑glucans remain modest.
Method transparency matters just as much as the number. If a COA lists beta‑glucans but doesn’t name the method, it may not be a specific beta‑glucan assay. Generic carbohydrate assays cannot distinguish glucan types reliably.
What you want is a method that clearly separates these categories. AOAC-recognized enzymatic approaches quantify total, alpha‑, and beta‑glucans, which sharply reduces ambiguity between fungal cell-wall material and cereal starch.
Also watch for simple administrative gaps:
When key information is missing, quality guidance suggests it may not be trustworthy. Before you debate chemistry, you need traceability.
And don’t let “potency” distract from cleanliness. Responsible sourcing includes heavy metals and other contaminant screening because concentrated products can amplify what you don’t want as well as what you do.
Finally, be extra careful with grain-rich mycelium products whose reports don’t distinguish fungal versus cereal-derived glucans. Retail testing has found some products likely contain more grain than fungal tissue, and without proper glucan separation, totals can quietly overstate “mushroom-ness.”
The most useful question isn’t “What percentage is best?” but “How many milligrams of beta‑glucans does this serving provide?” That shift turns COA numbers into something you can actually work with.
The calculation is straightforward: serving size (in mg) × beta‑glucan % ÷ 100. A 1,000 mg serving at 20% provides 200 mg. A 500 mg serving at 40% also provides 200 mg. This is why buyers are encouraged to show amounts in milligrams as well as percentages—so comparisons are real, not just marketing.
Thinking in milligrams keeps you from chasing a high percentage in isolation. A very concentrated extract can look impressive, but if the serving is tiny, the daily intake may be modest. A lower percentage with a practical serving can land in the same place.
Human research on polysaccharide-rich mushroom preparations often uses one to three grams of extract powder daily, with beta‑glucans commonly reported around 20–40%. Essentially, that can translate to several hundred milligrams up to around a gram of beta‑glucans per day, depending on the preparation.
In real-world practice, many people do well within a few hundred milligrams daily, adjusting based on constitution, sensitivity, and the larger well-being plan. The through-line is consistency over time, not chasing a single “perfect” number.
A practical way to use the COA:
And keep the bigger picture in view. Mushrooms aren’t just beta‑glucan delivery systems. Industry commentary points to networks of phenolics and terpenoids and other constituents that likely shape how a product feels in use.
That’s why a layered view is often the most grounded: beta‑glucans as the anchor, then species, extraction style, serving size, and broader profile. Some commentators describe this as pharmacopoeia‑style thinking—verified identity, measurable markers, clear processing details, and independent testing—rather than one easy metric.
The best practice isn’t tradition versus testing, but tradition supported by testing. A COA should sharpen discernment, not replace the sensory, cultural, and relational ways mushrooms have always been assessed.
Long before lab reports, quality was judged by appearance, aroma, texture, maturity, and place of growth. Cultivation standards still emphasize production conditions and careful handling—because how something is grown and processed matters.
Someone experienced with reishi, for example, often notices density, scent, and resinous character in ways a spreadsheet never could.
That kind of knowing is practitioner literacy—earned over time. Think of it like a musician’s ear: hard to “prove” in one moment, but unmistakably useful when you’ve trained it.
Modern testing strengthens that lineage when used well. Quality guidance increasingly recommends pairing sensory/contextual selection with beta‑glucan analysis and contaminant screening so the whole picture is clearer.
At a biochemical level, beta‑glucans are central to fungal structure. A recent review describes them as central to fungal cell‑wall architecture, which helps explain why they’re such a stable anchor—even while many finer details of the wider matrix are still being explored.
What this means is: the number is helpful precisely because it isn’t the whole story. It gives you a stable baseline, then leaves room for species-specific depth. More guides now encourage combining beta‑glucans with species‑specific markers and extraction details (for example, triterpene markers in reishi).
For an experienced practitioner, this layered approach feels natural. You honor lineage, form, preparation, place, and sensory quality—then use the COA as a modern safety net for identity, key markers, and cleanliness. That combination protects the integrity of the work.
Reading beta‑glucans on a COA is now a foundational practitioner skill. It supports more consistent outcomes, clearer communication, and sourcing choices that genuinely align with the traditions being honored.
Practically, keep it simple: request the batch report, confirm the COA lot number matches the product, look for third-party credibility, read beta‑ and alpha‑glucans together, and ensure contaminant screening is included.
These habits also shift the culture. When more practitioners expect transparent COAs instead of polished summaries, the industry is nudged toward better disclosure and better sourcing.
The strongest approach doesn’t reduce mushrooms to one metric. It combines beta‑glucans with species‑specific markers, clear identity verification, and purity checks—while still valuing sensory skill, lineage, and respect for cultural roots.
Apply COA literacy in practice with the Foundations of Medicinal Mushrooms Certification.
Explore Foundations of Medicinal Mushrooms →Thank you for subscribing.